No 10Y consistency score for revenue — its stored periods are half-year spaced, so quarter-over-same-quarter consistency is not computed.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annual revenue · last 8 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Jowell Global Ltd. (JWEL) stock was $2.40 as of Oct 6, 2026, 11:35 AM EDT, down 3.81% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +41.8% · 3-year avg -16.6%/yr · 5-year avg -50.2%/yr
Jowell Global Ltd. runs an e-commerce platform in China, focusing on the sale of cosmetics, health and nutritional supplements, and household goods.
Specialty Retail · Shanghai, SH
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
$0.00
Revenue
$88.85M
vs Estimate
$88.85M
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1JWEL | $5.21M | $2.40 | -3.81% | +41.81% | -50.17% | N/A | N/A |
| 2AZI | $5.14M | $1.15 | +0.44% | -98.96% | N/A | N/A | vs JWEL |
| 3INEO | $5.33M | $0.54 | -1.15% | -44.03% | N/A | N/A | vs JWEL |
| 4MKDW | $5.56M | $1.32 | -3.99% | -78.97% | N/A | N/A | vs JWEL |
| 5NWTG | $5.61M | $1.18 | +4.42% | -37.77% | N/A | N/A | vs JWEL |
| 6DBGI | $4.34M | $4.65 | +0.00% | -98.54% | -94.91% | N/A | vs JWEL |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$2.40
High
N/A
